Ameresco’s Q1 2026: A Biogas Bet, a Growing Backlog, and the Question of Guidance

Headline numbers and the backbone of the quarter

• Revenue: $401.5 million
• GAAP EPS: $(0.35) per share
• Non-GAAP EPS: $(0.33) per share
• Adjusted EBITDA: $40.5 million
• Revenue growth: approximately +14% year over year
• Awarded backlog: up 20% year over year to nearly $2.8 billion

So yes, the math says the business is growing its pipeline, even if the quarterly earnings print isn’t a tidy ribbon-cutting moment. Ameresco framed the quarter as a solid start, with revenue momentum and a backlog that keeps investors’ attention focused on project execution rather than a one-quarter pop in earnings.

What the executives emphasized

CEO George Sakellaris described Q1 as a solid start to the year, noting mid-teens revenue growth and a backlog that supports durable demand. He credited weather-driven volatility as well as a broad spectrum of opportunities in building efficiency, energy infrastructure, and ongoing operations and maintenance. The tone suggests Ameresco is betting that the combination of a diversified portfolio and a robust project pipeline can convert near-term earnings headwinds into longer-term growth trajectories.

Reading between the lines, the press release is less about a single quarter and more about the company’s ability to monetize a growing mix of project opportunities across its platforms. The EPS prints—GAAP and non-GAAP—reflect the usual timing differences inherent in a project-led business with sizable capital intensity. The company’s focus on backlog growth and new awards signals that management intends to translate pipeline into revenue in the quarters ahead, a dynamic analysts will watch against the EPS consensus and the evolving revenue forecast.

The HASI investment and Neogenyx Fuels

A centerpiece of the quarter was Ameresco’s announcement of a $400 million strategic investment from HASI into its biogas business, culminating in the formation of a new joint venture named Neogenyx Fuels. The company framed this as a milestone that will unlock value and accelerate growth in a capital-intensive segment where Ameresco has built a track record of decarbonization achievements. Management described monetizing a portion of the roughly $1.8 billion enterprise value already created in the biogas platform, which could meaningfully influence the revenue forecast and the trajectory of the business line.

In practical terms, the HASI deal is less a one-quarter headline and more a strategic lever. If Neogenyx Fuels starts turning the backers’ capital into recognizable earnings and expanded throughput, it could tilt the company’s optics toward higher growth and potentially more favorable EPS dynamics—though the first-order read remains a GAAP loss in the quarter and the near-term focus on execution and integration milestones.

Guidance update and what investors should watch

Ameresco indicated that 2026 guidance would be updated as a result of the HASI investment. That means expectations for revenue growth, margins, and potentially EPS trajectories are in flux as investors await the new framework. The key questions: does the Neogenyx Fuels initiative deliver a clear path to higher revenue and EBITDA in 2026 and 2027, and how quickly will the project backlog translate into realized earnings? In a sector where contracts, permitting, and project ramp can all stretch timelines, the guidance update will be a telling signal about management’s confidence in an accelerating growth profile.

Implications for peers and the broader sector

Ameresco’s strategy underscores several industry themes. First, backlog growth and awarded backlog are becoming more important than raw quarterly fluctuations as predictive indicators of mid-term performance. Second, strategic investments in decarbonization assets—specifically biogas—may become a more common capital-raising and value-creation tool for diversified energy infrastructure players. Third, the coexistence of GAAP and Non-GAAP earnings metrics remains a practical reality in this space, with the former capturing near-term profitability and the latter trying to show what the business could look like if project timing aligns with revenue ramps.

For sector peers, the HASI-N eogenyx blueprint could be a model—provided regulatory, competitive, and operational milestones align. The larger question for the industry is whether a more capital-light model can emerge from these partnerships, or if the capital-intensive nature of energy infrastructure remains a perpetual hurdle that needs patient investors and patient regulators alike.

Final take: a quarterly narrative with long-tail implications

AMRC’s first quarter reads like a prelude to a longer story. The topline momentum—$401.5 million in revenue and a 14% YoY gain—sits alongside a negative GAAP earnings print, which is the sort of thing that makes investors lean in and ask, "What specifically does the company have lined up to swing the trajectory?" The answer, in large part, centers on the HASI investment and the Neogenyx Fuels platform, which could tilt Ameresco’s earnings path toward higher growth as the biogas business matures and scales.

In the near term, the market will watch the 2026 guidance update for clarity on revenue forecasts and the expected pace of earnings contribution. If the partnership yields faster-than-expected backlog conversion and stronger operating leverage, AMRC could emerge from a quarter of negative GAAP prints into a narrative of disciplined growth in a sector that prizes long-term value over quarterly drama. In other words, the pipeline has legs—and with a little capital behind it, those legs might just sprint.